Lithera Reports Positive Clinical Study Results From a Second Phase IIa Trial for LIPO-102, a Novel Treatment for …

Lithera Reports Positive Clinical Study Results From a Second Phase IIa Trial for LIPO-102, a Novel Treatment for … SAN DIEGO — Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate and fluticasone propionate for selective, non-ablative fat reduction. Read more on GlobeNewswire via Yahoo! Finance

  • Share/Bookmark
by surgeon | Categories: Procedure | Tagged: , , , , , , , , , , , |
Enjoyed this article? Subscribe to the full RSS Feed

Share with others

No Responses so far | Have Your Say!

Leave a Feedback

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Categories

  • Calendar

    • September 2010
      M T W T F S S
      « Aug    
       12345
      6789101112
      13141516171819
      20212223242526
      27282930